Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F/A
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
News
TYPE
HEADLINE
FILED AT
6-K
NEWNanobiotix Management to Participate in November 2026 Investor Conferences
6-K
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors in Anti-PD-1-Resistant Primary Cutaneous Melan
6-K
Nanobiotix Publishes Monthly Information Regarding Share Capital and Voting Rights as of September 30, 2026
6-K
NANOBIOTIX Appoints Arnd Christ as Chief Financial Officer
6-K
Nanobiotix Reports Half-Year 2026 Financial Results and Corporate Updates
6-K
NANOBIOTIX Provides First Half 2026 Operational and Financial Update
